News

Back to Careers

Our SVP of Drug Development, Dr. Banmeet Anand, presented Juvena’s clinical stage metabolic program (JUV-161) that enhances muscle regeneration for the treatment of sarcopenia and myotonic dystrophy type 1 (DM1) at the International Conference of Frailty and Sarcopenia in Toulouse, France